相关实验视频
Updated: Jul 13, 2025

07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
172
在持续的IL-6受体对抗剂治疗期间,类风湿性关节炎患者的P450细胞染色体活性
Ann-Cathrine Dalgård Dunvald1, Kasper Søltoft2, Ekta Sheetal3
1Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, JB Winsløwsvej 19, 2, DK-5000, Odense C, Denmark.
European journal of clinical pharmacology
|October 13, 2023
概括
在类风湿性关节炎患者中,持续的抗IL-6R治疗可能会急性且暂时增加CYP3A4活性. 细胞P450酶活性的这种暂时增加可能会使抑制炎症的水平正常化,这需要进一步调查.
科学领域:
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
背景情况:
- 众所周知,炎症会抑制细胞染色体P450 (CYP) 酶的活性.
- 单剂量干白素6受体抗剂 (抗IL-6R) 已被证明可以逆转这种抑制.
- 持续抗IL-6R治疗对类风湿性关节炎 (RA) 患者的CYP活性的影响需要进一步评估.
研究的目的:
- 评估持续的抗IL-6R治疗对类风湿性关节炎患者的CYP酶活性的影响.
- 为了研究3周和12周治疗期间CYP3A4活性的潜在变化.
- 为了比较抗IL-6R疗法的影响与瘤坏死因子α (TNF-α) 抑制剂的影响.
主要方法:
- 一项临床药理动力学试验,涉及使用巴塞尔尾酒来评估CYP酶活性.
- 测量4β-基胆固醇/胆固醇比率作为CYP3A4活性的生物标志物.
- 一项回顾性研究,比较RA患者的抗IL-6R治疗与TNF-α抑制剂治疗.
主要成果:
- 三名患者的有限数据显示,在3周的抗IL-6R治疗后,对CYP3A4活性产生了微弱的,短暂的影响,在12周后,活性恢复到基线.
- 由于样本大小小,米达佐拉姆代谢比率 (CYP3A4) 的结果是不确定的.
- 在回顾性研究中没有观察到对4β-基胆固醇/胆固醇比的显著影响.
结论:
- 持续的抗IL-6R疗法可能会诱导RA患者急性,暂时增加CYP3A4活性.
- 这种效应可能归因于炎症抑制的CYP活性正常化.
- 需要进一步的研究来阐明这种潜在的短暂效应的机制.
相关概念视频
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
150
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
150
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
173
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
173
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
136
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
136

